{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:31:25Z","timestamp":1767652285991,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.tiv.2009.10.005","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:17:54Z","timestamp":1255839474000},"page":"630-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models"],"prefix":"10.1016","volume":"24","author":[{"given":"D.","family":"Beghin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Delongeas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Claude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Farinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Forestier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2009.10.005_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1357-4310(95)90793-9","article-title":"Intrauterine programming of adult disease","volume":"1","author":"Barker","year":"1995","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.tiv.2009.10.005_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.tiv.2008.10.007","article-title":"Development and characterisation of a new model of rat trophoblasts","volume":"23","author":"Beghin","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2009.10.005_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1358\/dnp.2002.15.9.840066","article-title":"The History of Thalidomide","volume":"15","author":"Botting","year":"2002","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.tiv.2009.10.005_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1472-8206.1999.tb00009.x","article-title":"The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac","volume":"13","author":"Bouer","year":"1999","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2009.10.005_bib5","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/bdrc.20027","article-title":"Mechanisms regulating toxicant disposition to the embryo during early pregnancy: an interspecies comparison","volume":"72","author":"Carney","year":"2004","journal-title":"Birth Defects Res. C. Embryo Today"},{"key":"10.1016\/j.tiv.2009.10.005_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0143-4004(98)91042-6","article-title":"Immunohistochemical identification of epithelial and mesenchymal cell types in the chorioallantoic and yolk sac placentae of the guinea-pig","volume":"19","author":"Carter","year":"1998","journal-title":"Placenta"},{"key":"10.1016\/j.tiv.2009.10.005_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1053\/plac.2001.0739","article-title":"Evolution of the placenta and fetal membranes seen in the light of molecular phylogenetics","volume":"22","author":"Carter","year":"2001","journal-title":"Placenta"},{"key":"10.1016\/j.tiv.2009.10.005_bib8","first-page":"520","article-title":"Thalidomide inhibits the angiogenic activity of culture supernatants of multiple myeloma cell line","volume":"23","author":"Chen","year":"2002","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.tiv.2009.10.005_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/scdb.2000.0156","article-title":"Genetic insights into trophoblast differentiation and placental morphogenesis","volume":"11","author":"Cross","year":"2000","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.tiv.2009.10.005_bib10","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1021\/bi9718043","article-title":"Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein","volume":"37","author":"Essodaigui","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.tiv.2009.10.005_bib11","unstructured":"Food and Drug Administration (FDA): Drug Interaction Studies\u2014Study Design, Data Analysis and Implications for Dosing and Labeling, 2004. Available from: <http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/briefing\/2004-4079B1_04_Topic2-TabA.pdf>."},{"key":"10.1016\/j.tiv.2009.10.005_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1046\/j.1360-0443.2000.95811411.x","article-title":"Treatment of opioid dependence in pregnant women","volume":"95","author":"Fischer","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.tiv.2009.10.005_bib13","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.tiv.2009.10.005_bib14","doi-asserted-by":"crossref","first-page":"21493","DOI":"10.1016\/S0021-9258(20)80566-3","article-title":"Fluorescent cellular indicators are extruded by the multidrug resistance protein","volume":"268","author":"Homolya","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2009.10.005_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0095-5108(18)30077-0","article-title":"The methadone-maintained pregnancy","volume":"26","author":"Kandall","year":"1999","journal-title":"Clin. Perinatol."},{"key":"10.1016\/j.tiv.2009.10.005_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0887-2333(00)00023-0","article-title":"Protection by free oxygen radical scavenging enzymes against salicylate-induced embryonic malformations in vitro","volume":"14","author":"Karabulut","year":"2000","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2009.10.005_bib17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jcp.10165","article-title":"Polarized glucose syncytiotrophoblast cell lines, TR-TBTs","volume":"193","author":"Kitano","year":"2002","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.tiv.2009.10.005_bib18","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/endo-118-4-1567","article-title":"Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae","volume":"118","author":"Kliman","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.tiv.2009.10.005_bib19","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.lfs.2005.10.016","article-title":"Effect of thalidomide affecting VEGF secretion, cell migration, adhesion and capillary tube formation of human endothelial EA.hy 926 cells","volume":"78","author":"Komorowski","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.tiv.2009.10.005_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0890-6238(98)00027-6","article-title":"Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice","volume":"12","author":"Lankas","year":"1998","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tiv.2009.10.005_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.tiv.2009.10.005_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/BF00160054","article-title":"Stage-specific distribution of P-glycoprotein in first-trimester and full-term human placenta","volume":"26","author":"MacFarland","year":"1994","journal-title":"Histochem. J."},{"key":"10.1016\/j.tiv.2009.10.005_bib23","first-page":"3458","article-title":"Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues","volume":"61","author":"Maliepaard","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.tiv.2009.10.005_bib24","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s11095-008-9537-z","article-title":"BCRP\/ABCG2 in the placenta: expression, function and regulation","volume":"25","author":"Mao","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.tiv.2009.10.005_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2174\/1567201043334731","article-title":"A review on the molecular mechanisms involved in the placental barrier","volume":"1","author":"Marin","year":"2004","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.tiv.2009.10.005_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tiv.2009.10.005_bib27","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.bcp.2005.03.030","article-title":"Role of P-glycoprotein in transplacental transfer of methadone","volume":"69","author":"Nanovskaya","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2009.10.005_bib28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1523-1747.1999.00744.x","article-title":"Thalidomide increases human keratinocyte migration and proliferation","volume":"113","author":"Nasca","year":"1999","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.tiv.2009.10.005_bib29","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/0002-9378(89)90932-0","article-title":"Aspirin differentially affects thromboxane and prostacyclin production by trophoblast and villous core compartments of human placental villi","volume":"161","author":"Nelson","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tiv.2009.10.005_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1520-6866(1997)17:1<I::AID-TCM1>3.0.CO;2-L","article-title":"Never-ending tales of the mode of the teratogenic action of thalidomide","volume":"17","author":"Neubert","year":"1997","journal-title":"Teratog. Carcinog. Mutagen"},{"key":"10.1016\/j.tiv.2009.10.005_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.reprotox.2004.04.014","article-title":"P-glycoprotein expression and distribution in the rat placenta during pregnancy","volume":"18","author":"Novotna","year":"2004","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tiv.2009.10.005_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-291X(03)00327-9","article-title":"Effects of maturation on RNA transcription and protein expression of four MRP genes in human placenta and in BeWo cells","volume":"303","author":"Pascolo","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tiv.2009.10.005_bib33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/jps.1108","article-title":"Influence of P-glycoprotein on the transplacental passage of cyclosporine","volume":"90","author":"Pavek","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2009.10.005_bib34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1124\/jpet.102.048470","article-title":"Examination of the functional activity of P-glycoprotein in the transplacental barrier using rhodamine 123","volume":"305","author":"Pavek","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2009.10.005_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/(SICI)1097-0045(20000215)42:3<172::AID-PROS2>3.0.CO;2-R","article-title":"Contrasting effects of aspirin on prostate cancer cells: suppression of proliferation and induction of drug resistance","volume":"42","author":"Rotem","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.tiv.2009.10.005_bib36","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1203\/01.PDR.0000181381.82856.23","article-title":"Placental phenotypes of intrauterine growth","volume":"58","author":"Sibley","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.tiv.2009.10.005_bib37","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI7963","article-title":"Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure","volume":"104","author":"Smit","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tiv.2009.10.005_bib38","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0140-6736(62)91943-8","article-title":"Thalidomide and congenital abnormalities","volume":"1","author":"Somers","year":"1962","journal-title":"Lancet"},{"key":"10.1016\/j.tiv.2009.10.005_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.106.105023","article-title":"Expression and transport activity of breast cancer resistance protein (Bcrp\/ABCG2) in dually perfused rat placenta and HRP-1 cell line","volume":"319","author":"Staub","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2009.10.005_bib40","doi-asserted-by":"crossref","first-page":"R1495","DOI":"10.1152\/ajpregu.2000.279.4.R1495","article-title":"Expression of members of the multidrug resistance protein family in human term placenta","volume":"279","author":"St-Pierre","year":"2000","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.tiv.2009.10.005_bib41","unstructured":"TERIS http:\/\/www.thomsonhc.com\/ last reviewed May 2006."},{"key":"10.1016\/j.tiv.2009.10.005_bib42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0890-6238(00)00071-X","article-title":"Functional expression of P-glycoprotein in primary cultures of human cytotrophoblasts and BeWo cells","volume":"14","author":"Utoguchi","year":"2000","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.tiv.2009.10.005_bib43","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0891-5849(94)00157-F","article-title":"Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas","volume":"18","author":"Wang","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.tiv.2009.10.005_bib44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00228-005-0035-5","article-title":"Changes to methadone clearance during pregnancy","volume":"61","author":"Wolff","year":"2005","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.tiv.2009.10.005_bib45","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpba.2005.02.041","article-title":"Determination of thalidomide by high performance liquid chromatography: plasma pharmacokinetic studies in the rat","volume":"39","author":"Yang","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.tiv.2009.10.005_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1124\/jpet.106.103606","article-title":"A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor","volume":"319","author":"Yang","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2009.10.005_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0002-9378(86)90823-9","article-title":"Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans","volume":"155","author":"Ylikorkala","year":"1986","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tiv.2009.10.005_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0169-409X(02)00174-6","article-title":"Efflux transporters of the human placenta","volume":"55","author":"Young","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.tiv.2009.10.005_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00280-005-0087-3","article-title":"Thalidomide does not interact with P-glycoprotein","volume":"57","author":"Zimmermann","year":"2006","journal-title":"Cancer Chemother. Pharmacol."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309002999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233309002999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:30:52Z","timestamp":1760135452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233309002999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0887233309002999"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2009.10.005","relation":{},"ISSN":["0887-2333"],"issn-type":[{"type":"print","value":"0887-2333"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effects of drugs on P-glycoprotein expression and activity using rat and human trophoblast models","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2009.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}